Gene Therapy Seeks FDA Approval After Treating Just 2 Patients

A groundbreaking gene-editing treatment could reach patients faster than ever before, as Prime Medicine asks the FDA to approve their therapy after just two successful treatments.

The drug uses a revolutionary CRISPR technique to fix a genetic disorder that leaves patients vulnerable to deadly infections.